“Activism in Israel still remains focused on remuneration, board independence, and board diversity. This is due in part to the fact that most activism in Israel, outside of short activism, is not carried out by hedge funds but rather by individuals or groups of shareholders”

Geoff Serednesky, Managing Director

Country:
Israel

Country: Israel

Average % of insider ownership:

9.43

Activism
Threat Level


To learn more about this country, please click on the tabs below


Shareholder activism and engagement is governed by Israeli Companies Law, which provides certain basic rights to shareholders. The law builds in certain anti-takeover protections that safeguard incumbent boards of directors and limit potential hostile activism; however, this has resulted in increased reverse triangular mergers.

Conversely, return-based activism is particularly limited in Israel as short-term corporate profits and other surpluses may only be paid out in part. Due to the enhanced disclosure requirements in the U.S. (where many Israeli public companies are traded), current issues like executive compensation have become commonplace in Israeli capital markets.

Shareholders reaching or exceeding a five percent threshold must disclose their voting interests within one business day or face significant penalties.

Israeli Companies Law allows shareholders that own at least one percent to request that the company’s board of directors include a subject on the agenda of a general shareholder meeting.

If the investor owns at least five percent, they have the ability request a shareholder meeting.

Companies may have supermajority voting requirements to change the means or method for the election of directors. While poison pills are not yet recognized by Israeli law, staggered three-year term boards are common practice.


Top Campaigns by Type

1. Gain Board Representation
2. Remuneration
3. Removal of CEO or Other Board Member

Campaigns By Year

Total
Campaigns

50

Notable Invested Activists

Benny Landa
Amir Efrati (Brosh Capital and Exodus Capital)
Y.M. Dekel Holdings and Investments Ltd

Recent activism campaigns

Teva Pharmaceutical Industries Ltd
VS.
Benny Landa
magicJack VocalTec
VS.
Twinleaf Management
NeuroDerm Ltd.
VS.
Viceroy Research

Total Active
Campaigns

2

Contact FTI Consulting

Geoff Serednesky

Capital Markets Research and Activist Engagement
Managing Director
+1 312 861 4721
Geoff.Serednesky@FTIConsulting.com

Ed Bridges

Senior Managing Director
+44 (0)20 3727 1067
Edward.Bridges@FTIConsulting.com